Literature DB >> 22749663

Similarities and differences in fluorodeoxyglucose positron emission tomography/computed tomography findings in spondyloarthropathy, polymyalgia rheumatica and rheumatoid arthritis.

Hiroyuki Yamashita1, Kazuo Kubota, Yuko Takahashi, Ryogo Minamimoto, Miyako Morooka, Hiroshi Kaneko, Toshikazu Kano, Akio Mimori.   

Abstract

OBJECTIVES: We assessed fluorine-18 ((18)F)-labelled fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) findings in patients with seronegative spondyloarthritis (SpA), polymyalgia rheumatica (PMR), and rheumatoid arthritis (RA).
METHODS: We studied 53 patients with SpA (n=21), PMR (n=16), or RA (n=16) admitted to our hospital between 2006 and 2011. Disease activity in the ischial tuberosities, greater trochanters, spinous processes, vertebral bodies, and sacroiliac joints (SIJ) were evaluated by determining FDG accumulation using maximum standardized uptake values (SUV(max)) and FDG scores.
RESULTS: SUV(max) for ischial tuberosities was significantly higher in PMR than SpA or RA. SUV(max) for greater trochanters and spinous processes was significantly higher in PMR than RA (P<0.001) and significantly higher in SpA than in PMR or RA for SIJ (P=0.01). No significant difference in vertebral scores was observed among groups (P=0.488). FDG scores yielded similar results. X-ray findings were consistent with PET/CT findings in 3/15 (20%) patients with sacroiliitis, whereas magnetic resonance imaging findings were consistent with PET/CT findings in 4/7 (57.1%) patients.
CONCLUSIONS: PET/CT detection of inflammation in the ischial tuberosities, greater trochanters, and spinous processes discriminated between PMR and RA, but not between SpA and PMR. PET/CT findings can distinguish SpA from RA and PMR and are useful for the early diagnosis of sacroiliitis.
Copyright © 2012 Société française de rhumatologie. Published by Elsevier SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22749663     DOI: 10.1016/j.jbspin.2012.04.006

Source DB:  PubMed          Journal:  Joint Bone Spine        ISSN: 1297-319X            Impact factor:   4.929


  11 in total

1.  [Positron emission tomography/computed tomography in rheumatology].

Authors:  T Derlin
Journal:  Z Rheumatol       Date:  2017-09       Impact factor: 1.372

2.  Value of (18)F-FDG PET/CT for therapeutic assessment of patients with polymyalgia rheumatica receiving tocilizumab as first-line treatment.

Authors:  X Palard-Novello; S Querellou; M Gouillou; A Saraux; T Marhadour; F Garrigues; R Abgral; P Y Salaün; V Devauchelle-Pensec
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-01-11       Impact factor: 9.236

3.  Comment on: FDG PET in the early diagnosis of large-vessel vasculitis.

Authors:  Zdeněk Rehák; Petr Szturz
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-01-17       Impact factor: 9.236

4.  Early onset polymyalgia rheumatica: two rare cases under age of 50.

Authors:  Jinyoung Park; Duk Hyun Sung
Journal:  Skeletal Radiol       Date:  2017-03-21       Impact factor: 2.199

Review 5.  Use of Imaging in Axial Spondyloarthritis for Diagnosis and Assessment of Disease Remission in the Year 2022.

Authors:  Ann-Sophie De Craemer; Zuzanna Łukasik; Philippe Carron
Journal:  Curr Rheumatol Rep       Date:  2022-10-15       Impact factor: 4.686

Review 6.  Clinical value of whole-body PET/CT in patients with active rheumatic diseases.

Authors:  Hiroyuki Yamashita; Kazuo Kubota; Akio Mimori
Journal:  Arthritis Res Ther       Date:  2014       Impact factor: 5.156

7.  Differentiation between Polymyalgia Rheumatica (PMR) and Elderly-Onset Rheumatoid Arthritis Using 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography: Is Enthesitis a New Pathological Lesion in PMR?

Authors:  Daisuke Wakura; Takuya Kotani; Tohru Takeuchi; Tsuyoshi Komori; Shuzo Yoshida; Shigeki Makino; Toshiaki Hanafusa
Journal:  PLoS One       Date:  2016-07-06       Impact factor: 3.240

8.  Incidental Unilateral Tuberculous Sacroiliitis Detected by 18F-FDG PET/CT in a Patient with Abdominal Tuberculosis.

Authors:  Domenico Albano; Giorgio Treglia; Paolo Desenzani; Francesco Bertagna
Journal:  Asia Ocean J Nucl Med Biol       Date:  2017

9.  Adalimumab and sulfasalazine in alleviating sacroiliac and aortic inflammation detected in PET/CT in patients with axial spondyloarthritis: PETSPA.

Authors:  Juha-Pekka Kaijasilta; Anne M Kerola; Riitta Tuompo; Heikki Relas; Antti Loimaala; Hannu Koivu; Jukka Schildt; Tuomas Kerola; Kari Eklund; Markku J Kauppi; Tuomo V M Nieminen
Journal:  Immun Inflamm Dis       Date:  2021-11-09

Review 10.  PET imaging of inflammation biomarkers.

Authors:  Chenxi Wu; Fang Li; Gang Niu; Xiaoyuan Chen
Journal:  Theranostics       Date:  2013-06-24       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.